Skip to content

The effect of Chinese children's UGT1A9 gene rs13418420 site polymorphism on the efficacy of medium-long chain propofol in painless gastroscopic venous anesthesia

The effect of Chinese children's UGT1A9 gene rs13418420 site polymorphism on the efficacy of medium-long chain propofol in painless gastroscopic venous anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114349
Enrollment
Unknown
Registered
2025-12-10
Start date
2025-03-21
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal pain

Interventions

Female TT group:Medium and long-chain propofol with a concentration of 10mg/ml was used as the test drug. The initial dose of medium and long-chain propofol was set at 3mg/kg. The induction dose of pr
Female TC group:Medium and long-chain propofol with a concentration of 10mg/ml was used as the test drug. The initial dose of medium and long-chain propofol was set at 3mg/kg. The induction dose of pr

Sponsors

Guangdong Provincial Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Age 5-12 years old, body mass index 14-24 kg/m^2; 2.Children undergoing gastroscopy under intravenous general anesthesia; 3.The affected children and their families understand the research procedures and purposes, and voluntarily participate in this research; 4.Receive medium-long-chain propofol induction and elective surgery.

Exclusion criteria

Exclusion criteria: 1.ASA >= level 3 2. Unable to cooperate with intravenous induction 3. Propofol allergy and other contraindications for propofol use 4. A syndrome that significantly affects cognitive development, with a total developmental quotient of less than 70 points calculated based on the Griffiths Mental Development Scale for individuals with obvious neurological defects or delayed development of the mental nervous system 5. There are genetic metabolic diseases such as congenital hypothyroidism, phenylketonuria, and methylmalonic acidemia 6. Abnormal liver and kidney functions 7.Participate in other clinical studies within 3 months

Design outcomes

Primary

MeasureTime frame
ED50 of medium to long chain propofol for induction of pediatric general anesthesia gastroscopy;

Secondary

MeasureTime frame
Perioperative Blood Pressure;Medium-long chain propofol dosage per kilogram of body weight per unit time;Perioperative Heart Rate;

Countries

China

Contacts

Public ContactYun Wang

Guangdong Provincial Maternal and Child Health Hospital

529131440@qq.com+86 20 3915 1759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026